tiprankstipranks
Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
NASDAQ:OACC
US Market

Oaktree Acquisition Corp. III Life Sciences Class A (OACC) Financial Statements

Compare
0 Followers

Oaktree Acquisition Corp. III Life Sciences Class A Financial Overview

Oaktree Acquisition Corp. III Life Sciences Class A's market cap is currently $261.81M. The company's EPS TTM is $; its P/E ratio is 27.87; Oaktree Acquisition Corp. III Life Sciences Class A is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -1.20M$ -703.00
EBITDA$ -1.20M$ 0.00
Net Income$ 7.29M$ 2.66K
Balance Sheet
Cash & Short-Term Investments$ 1.43M$ 1.36M
Total Assets$ 203.11M$ 195.25M
Total Debt$ 0.00$ 11.82K
Net Debt$ -1.43M$ -1.35M
Total Liabilities$ 8.32M$ 7.75M
Stockholders' Equity$ -6.77M$ 187.50M
Cash Flow
Free Cash Flow$ -422.08K$ -179.00
Operating Cash Flow$ -422.08K$ -179.00
Investing Cash Flow$ 500.00K$ -191.99M
Financing Cash Flow$ 0.00$ 193.44M
Currency in USD

Oaktree Acquisition Corp. III Life Sciences Class A Earnings and Revenue History

Oaktree Acquisition Corp. III Life Sciences Class A Debt to Assets

Oaktree Acquisition Corp. III Life Sciences Class A Cash Flow

Oaktree Acquisition Corp. III Life Sciences Class A Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.